TuHURA Biosciences (HURA) Goodwill & Intangibles (2016 - 2026)

TuHURA Biosciences' (HURA) quarterly Goodwill & Intangibles came in at $10.7 million in Q1 2026, little changed quarter-over-quarter from $10.7 million in Q4 2025.

TuHURA Biosciences (HURA) Goodwill & Intangibles (2016 - 2026) Analysis & Trends

TuHURA Biosciences' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $10.7 million for Q1 2026.

  • On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $10.7 million, changed N/A from the prior year.
  • Goodwill & Intangibles held at $10.7 million in Q1 2026 per HURA's latest filing, from $10.7 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $13.6 million in Q3 2025 and bottomed at $10.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 TuHURA Biosciences 132.62 Mn 132.62 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 10.74 Mn
Dec 31, 2025 10.74 Mn
Sep 30, 2025 13.55 Mn
Jun 30, 2025 10.74 Mn
Sep 30, 2020 1,000.00
Jun 30, 2020 2,000.00
Mar 31, 2020 3,659.00
Dec 31, 2019 6,460.00
Sep 30, 2019 9,261.00
Jun 30, 2019 12,062.00
Mar 31, 2019 14,863.00
Dec 31, 2018 17,665.00
Sep 30, 2018 21,752.00
Jun 30, 2018 28,411.00
Mar 31, 2018 35,070.00
Dec 31, 2017 29,080.00
Sep 30, 2017 34,685.00
Jun 30, 2017 40,290.00
Mar 31, 2017 24,443.00
Dec 31, 2016 28,301.00